We constructed a nomogram to predict the PFS of 86 NSCLC patients of the selected cohort [MSKCC, J Clin Oncol 2018] based on the integrated information of clinicopathologic features, targeted sequencing, and PD-L1 expression. The gene discussed is CD274; the disease is non-small cell lung carcinoma.